• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Director Ludlum Ken was granted 52,817 shares (SEC Form 4)

    12/9/24 4:03:25 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care
    Get the next $DHAI alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    LUDLUM KEN

    (Last) (First) (Middle)
    C/O DIH HOLDING US, INC
    77 ACCORD PARK DR SUITE D-1

    (Street)
    NORWELL, MA 02061

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    DIH HOLDING US, INC. [ DHAI ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    12/05/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock 12/05/2024 A(1) 52,817(1) A(1) $1.42(1) 52,817(1) D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. The shares are being issued as part of the Company's board compensation package which is comprised of both cash and stock compensation. These shares are being issued pursuant to that agreement under the Company's Equity Compensation Plan. This issuance is for 3 quarters of service, which equates to $75,000.14 and is based upon $1.42 per share
    /s/ Kenneth Ludlum By Power of Attorney: /s/ Lynden Bass, CFO DIH Holding US, Inc 12/09/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $DHAI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DHAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DHAI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • DIH Announces Third Quarter 2025 Financial Results

      NORWELL, Mass., Feb. 14, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporates visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the third fiscal quarter ended December 31, 2024. Recent Highlights Revenue of $15.1 million for the quarter ended December 31, 2024, representing a decline of 21% over the prior year periodDevice revenue of $11.7 million and service reven

      2/14/25 5:07:01 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Expands Strategic Partnership with Zahrawi Group

      NORWELL, Mass. and DUBAI, United Arab Emirates, Feb. 04, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the expansion of their strategic partnership with Zahrawi Group (MTC Company), DIH's representative and sales partner, to include Saudi Arabia.  Building on a successful collaboration that started in 2019, the partnership now spans four countries: th

      2/4/25 8:00:00 AM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Announces Closing of $4.6 Million Public Offering

      NORWELL, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the closing of its previously announced public offering of an aggregate of 5,937,100 units at a public offering price of $0.7832 per unit. Each unit consists of one share of Class A common stock and one Class A warrant to purchase one share of Class A common stock

      2/3/25 4:05:00 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care

    $DHAI
    SEC Filings

    See more
    • SEC Form 424B3 filed by DIH Holdings US Inc.

      424B3 - DIH HOLDING US, INC. (0001883788) (Filer)

      5/5/25 4:35:42 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • SEC Form 424B3 filed by DIH Holdings US Inc.

      424B3 - DIH HOLDING US, INC. (0001883788) (Filer)

      5/5/25 4:30:39 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Holdings US Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - DIH HOLDING US, INC. (0001883788) (Filer)

      5/2/25 4:30:14 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care

    $DHAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

      SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

      11/14/24 6:07:49 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

      SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

      11/14/24 12:46:18 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13D filed by DIH Holdings US Inc.

      SC 13D - DIH HOLDING US, INC. (0001883788) (Subject)

      2/20/24 5:18:47 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care

    $DHAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Baucus Max was granted 52,817 shares (SEC Form 4)

      4 - DIH HOLDING US, INC. (0001883788) (Issuer)

      12/9/24 4:03:26 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • Director Chen Cathryn was granted 105,634 shares and acquired 4,885,173 shares (SEC Form 4)

      4 - DIH HOLDING US, INC. (0001883788) (Issuer)

      12/9/24 4:03:23 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • Director Eberts F Samuel Iii was granted 105,634 shares (SEC Form 4)

      4 - DIH HOLDING US, INC. (0001883788) (Issuer)

      12/9/24 4:03:23 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care

    $DHAI
    Leadership Updates

    Live Leadership Updates

    See more
    • DIH Appoints Shepherd Center as a DIH Center of Excellence

      NORWELL, Mass. and ATLANTA, Dec. 23, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Shepherd Center as DIH Center of Excellence. Through this partnership, DIH and Shepherd Center aim to further enhance rehabilitation outcomes and drive advancements in rehabilitation, creating new opportunities for patient recovery. The DIH Center of

      12/23/24 7:00:00 AM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Appoints Sheltering Arms Institute as a DIH Center of Excellence

      NORWELL, Mass. and RICHMOND, Va., Dec. 16, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the designation of Sheltering Arms Institute, a collaboration with VCU Health, as DIH Center of Excellence. By partnering with Sheltering Arms Institute, DIH continues to build a strong presence among top-tier healthcare providers dedicated to enhancing patient re

      12/16/24 4:05:00 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Appoints Dietmar Dold as Chief Operating Officer

      NORWELL, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a leading global robotics and virtual reality ("VR") technology provider in the rehabilitation and human performance industry, today announced the appointment of Mr. Dietmar Dold as Chief Operating Officer, effective immediately.  Mr. Dold brings to DIH over 25 years of operating experience across multiple industries, and has demonstrated significant expertise in driving innovative transformation on a global scale. In his role as Chief Operating Officer, Mr. Dold will define and lead DIH's multi-group operating strategy, where he is expected to optimize manufacturing and sourcing initiatives, buil

      11/4/24 8:17:00 AM ET
      $DHAI
      Medical/Dental Instruments
      Health Care